Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC867126236;26237;26238 chr2:178715175;178715174;178715173chr2:179579902;179579901;179579900
N2AB835425285;25286;25287 chr2:178715175;178715174;178715173chr2:179579902;179579901;179579900
N2A742722504;22505;22506 chr2:178715175;178715174;178715173chr2:179579902;179579901;179579900
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: P
  • RefSeq wild type transcript codon: CCA
  • RefSeq wild type template codon: GGT
  • Domain: Ig-72
  • Domain position: 29
  • Structural Position: 43
  • Q(SASA): 0.7321
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
P/A rs373927854 -0.207 0.998 D 0.662 0.436 0.349870743963 gnomAD-2.1.1 4.02E-06 None None None None I None 0 0 None 0 5.56E-05 None 0 None 0 0 0
P/L rs2077292301 None 1.0 N 0.685 0.491 0.746293652351 gnomAD-4.0.0 1.59142E-06 None None None None I None 0 0 None 0 0 None 0 0 2.85873E-06 0 0
P/S None None 1.0 N 0.679 0.473 0.362960570912 gnomAD-4.0.0 2.40065E-06 None None None None I None 0 0 None 0 0 None 0 0 2.62501E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
P/A 0.2806 likely_benign 0.2221 benign -0.661 Destabilizing 0.998 D 0.662 neutral D 0.534654268 None None I
P/C 0.8987 likely_pathogenic 0.8654 pathogenic -0.313 Destabilizing 1.0 D 0.667 neutral None None None None I
P/D 0.7919 likely_pathogenic 0.7265 pathogenic -0.753 Destabilizing 0.998 D 0.657 neutral None None None None I
P/E 0.7168 likely_pathogenic 0.6273 pathogenic -0.836 Destabilizing 0.999 D 0.669 neutral None None None None I
P/F 0.8958 likely_pathogenic 0.8483 pathogenic -0.801 Destabilizing 1.0 D 0.629 neutral None None None None I
P/G 0.7261 likely_pathogenic 0.6467 pathogenic -0.833 Destabilizing 1.0 D 0.719 prob.delet. None None None None I
P/H 0.6251 likely_pathogenic 0.5426 ambiguous -0.498 Destabilizing 1.0 D 0.641 neutral None None None None I
P/I 0.7187 likely_pathogenic 0.6675 pathogenic -0.33 Destabilizing 1.0 D 0.664 neutral None None None None I
P/K 0.7834 likely_pathogenic 0.6956 pathogenic -0.579 Destabilizing 1.0 D 0.659 neutral None None None None I
P/L 0.421 ambiguous 0.3554 ambiguous -0.33 Destabilizing 1.0 D 0.685 prob.neutral N 0.494264385 None None I
P/M 0.7509 likely_pathogenic 0.7002 pathogenic -0.347 Destabilizing 1.0 D 0.645 neutral None None None None I
P/N 0.7306 likely_pathogenic 0.6726 pathogenic -0.165 Destabilizing 1.0 D 0.683 prob.neutral None None None None I
P/Q 0.5757 likely_pathogenic 0.4884 ambiguous -0.407 Destabilizing 1.0 D 0.647 neutral N 0.482841946 None None I
P/R 0.6104 likely_pathogenic 0.5006 ambiguous -0.083 Destabilizing 1.0 D 0.673 neutral D 0.535886419 None None I
P/S 0.4377 ambiguous 0.3571 ambiguous -0.447 Destabilizing 1.0 D 0.679 prob.neutral N 0.489718481 None None I
P/T 0.3841 ambiguous 0.3273 benign -0.441 Destabilizing 1.0 D 0.673 neutral N 0.517703303 None None I
P/V 0.5584 ambiguous 0.4902 ambiguous -0.407 Destabilizing 1.0 D 0.692 prob.neutral None None None None I
P/W 0.9603 likely_pathogenic 0.9394 pathogenic -0.931 Destabilizing 1.0 D 0.678 prob.neutral None None None None I
P/Y 0.8587 likely_pathogenic 0.8022 pathogenic -0.635 Destabilizing 1.0 D 0.64 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.